Michael
Analyst
Leerink Partners
Equibles does not estimate personal net worth.
About Michael
Michael is recorded as Analyst at Leerink Partners. Michael has spoken on 9 earnings calls and 2 other investor events across 11 companies, most recently for 10x Genomics, Inc. on November 5, 2026. Those appearances were for 10x Genomics, Inc. (TXG), Prospect Capital Corp (PSEC), FUCHS SE, Cogent Communications Holdings, Inc. (CCOI), Lantern Pharma Inc. (LTRN) and 6 other companies. The companies whose calls Michael spoke on are classified in the Healthcare, Financial Services, Basic Materials and Communication Services sectors.
Michael on recent calls
“I think I wanted to pivot the conversation to a single cell. Could you offer any color on the APEX transition, like how far along we are there? I know you've also talked about APEX being the most, or the flex.”
“Good day, and welcome to the Prospect Capital First Quarter 2027 Earnings Release and Conference Call. All participants will be in a listen-only mode. Should you need assistance, please signal Conference Specialist by pressing the star key followed by zero.”
“The first one is looking into your organic growth, which you have reported in the third quarter, and my understanding is it's largely price-driven. However, we see some regional differences.”
“We're going to start with to have Dave Schaefer from Cogent here with us. He's kind enough to come every year, and great to hear the latest from you, Dave. So thank you again.”
“Two questions, Pana, one on LP300 and then the other on OMAI. Just on LP300, can you talk about where are you in the data analysis? It's obviously nice to see the PFS stretching out a little bit more, but how mature is this data set?”
Affiliation history
-
Leerink Partners
Analyst
Source not stated
Current
Company network
Asset Management · Financial Services
FUCHS SE
Specialty Chemicals · Basic Materials
Telecom Services · Communication Services
LTRN
Biotechnology · Healthcare
CARG
Internet Content & Information · Communication Services
STANDARD LIFE PLC
Insurance - Life · Financial Services
Drug Manufacturers - Specialty & Generic · Healthcare
AMUNDI
Asset Management · Financial Services
Recent activity
-
-
-
Earnings call
Analyst's Conference Call - 9M 2026 Results
FUCHS SE
-
-
-
-
-
Earnings call
2025 Full Year Results
STANDARD LIFE PLC
-
-
Earnings call
Amundi Q4 & Full Year 2025 Results Presentation to Investors & Analysts
AMUNDI
-